1. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1040,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1130KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
2. |
Guidelines for pain management in cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1040,
1996,
Page 3-3
&NA;,
Preview
|
PDF (1013KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
3. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1040,
1996,
Page 4-4
&NA;,
Preview
|
PDF (1072KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
4. |
Tricyclic antidepressants for fibromyalgia |
|
Inpharma Weekly,
Volume &NA;,
Issue 1040,
1996,
Page 5-5
&NA;,
Preview
|
PDF (1118KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
5. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1040,
1996,
Page 6-6
&NA;,
Preview
|
PDF (1044KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
6. |
First human trial of therapeutic vaccine for cervical cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1040,
1996,
Page 7-7
&NA;,
Preview
|
PDF (950KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1040,
1996,
Page 8-8
&NA;,
Preview
|
PDF (1078KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
8. |
Anti-TNF-&agr; antibodies studied in inflammatory bowel disease |
|
Inpharma Weekly,
Volume &NA;,
Issue 1040,
1996,
Page 9-11
Gill Higgins,
Preview
|
PDF (3185KB)
|
|
摘要:
A new treatment for Crohn's disease has shown good efficacy and tolerability in its debut double-blind, placebo-controlled trial. The new agent is Centocor's cenTNF, a chimaeric anti-tumour necrosis factor-&agr; (TNF-&agr;) antibody. In the study, a clinical response was seen as early as 2 weeks after treatment and was maintained for 12 weeks in over 60% of responding patients. Less encouraging results have been seen with cenTNF in patients with ulcerative colitis, but the data in this patient population are only preliminary. Findings from these studies were presented at Digestive Disease Week [San Francisco, US; May 1996], during which the results of the first placebo-controlled trial of Celltech's CDP-571, a humanised version of the anti-TNF-&agr; antibody, were also presented.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
9. |
Interferon news in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1040,
1996,
Page 12-12
&NA;,
Preview
|
PDF (1005KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
10. |
Tolterodine: a new drug for urinary incontinence |
|
Inpharma Weekly,
Volume &NA;,
Issue 1040,
1996,
Page 13-14
Steve Winter,
Preview
|
PDF (2061KB)
|
|
摘要:
Urinary incontinence is estimated to affect more than 30 million people in the developed world. However, while this disorder is treatable and often curable in most individuals, the efficacy and tolerability of currently available therapeutic agents is far from optimal. Tolterodine*is a new muscarinic antagonist specifically developed for the treatment of urinary urge incontinence and other symptoms of detrusor overactivity. In this week's issue,Inpharma® maps the progress of this interesting compound in preclinical studies and preliminary phase II clinical trials.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|